Evidence map›Paper›PMID 27410234›Full record

ArticlePloS one2016

Modeling the Impact of Uganda's Safe Male Circumcision Program: Implications for Age and Regional Targeting.

Katharine Kripke, Andrea Vazzano, William Kirungi, Joshua Musinguzi, Alex Opio, Rhobbinah Ssempebwa, Susan Nakawunde, Sheila Kyobutungi, Juliet N Akao, Fred Magala and 3 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Katharine KripkeHealth Policy Project, Avenir Health, Washington, D.C., United States of America.
Andrea VazzanoHealth Policy Project, Futures Group, Washington, D.C., United States of America.
William KirungiMinistry of Health, Kampala, Uganda.
Joshua MusinguziMinistry of Health, Kampala, Uganda.
Alex OpioMinistry of Health, Kampala, Uganda.
Rhobbinah SsempebwaU.S. Agency for International Development (USAID), Kampala, Uganda.
Susan NakawundeU.S. Agency for International Development (USAID), Kampala, Uganda.
Sheila KyobutungiU.S. Agency for International Development (USAID), Kampala, Uganda.
Juliet N AkaoU.S. Department of Defense, Kampala, Uganda.
Fred MagalaMakerere University Walter Reed Project, Kampala, Uganda.
George MwiduMakerere University Walter Reed Project, Kampala, Uganda.
Delivette CastorUSAID, Washington, D.C., United States of America.
Emmanuel NjeuhmeliUSAID, Washington, D.C., United States of America.ORCID http://orcid.org/0000-0001-5370-4827
Ministry of Health · UGMakerere University Walter Reed Project · UGUnited States Agency for International Development · USAvenir Health · USFutures Group (United States) · USUnited States Department of Defense · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUganda aims to provide safe male circumcision (SMC) to 80% of men ages 15-49 by 2016. To date, only 2 million men have received SMC of the 4.2 million men required. In response to age and regional trends in SMC uptake, the country sought to re-examine its targets with respect to age and subnational region, to assess the program's progress, and to refine the implementation approach. METHODS AND

findingsThe Decision Makers' Program Planning Tool, Version 2.0 (DMPPT 2.0), was used in conjunction with incidence projections from the Spectrum/AIDS Impact Module (AIM) to conduct this analysis. Population, births, deaths, and HIV incidence and prevalence were used to populate the model. Baseline male circumcision prevalence was derived from the 2011 AIDS Indicator Survey. Uganda can achieve the most immediate impact on HIV incidence by circumcising men ages 20-34. This group will also require the fewest circumcisions for each HIV infection averted. Focusing on men ages 10-19 will offer the greatest impact over a 15-year period, while focusing on men ages 15-34 offers the most cost-effective strategy over the same period. A regional analysis showed little variation in cost-effectiveness of scaling up SMC across eight regions. Scale-up is cost-saving in all regions. There is geographic variability in program progress, highlighting two regions with low baseline rates of circumcision where additional efforts will be needed.

conclusionFocusing SMC efforts on specific age groups and regions may help to accelerate Uganda's SMC program progress. Policy makers in Uganda have already used model outputs in planning efforts, proposing males ages 10-34 as a priority group for SMC in the 2014 application to the Global Fund's new funding model. As scale-up continues, the country should also consider a greater effort to expand SMC in regions with low MC prevalence.

Indexed as

AdolescentAdultAge FactorsChildCircumcision, MaleCost-Benefit AnalysisGeographyHIV InfectionsHumansMaleMiddle AgedNational Health ProgramsUgandaYoung Adult

Identifiers

PMID27410234
PMCPMC4943628
OpenAlexW2460665175

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.